A healthcare provider — from New York City-based PWNHealth, which partners with Viome — reviews the questionnaire request within 48 hours. presented by Sponsored Post ...

PWNHealth, a provider of healthcare diagnostic testing enablement solutions, has secured a “significant” investment led by Spectrum Equity. Other investors were Blue Venture Fund and Sandbox ...

More than 400 patients who signed up to take a pioneering oncology detection test developed by US biotech company Grail received erroneous letters last month suggesting they may have developed ...

RALEIGH, N.C., Dec. 17, 2020 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the enhancement of its COVID-19 Monitoring Program with the addition of at-home COVID-19 testing ...

PWNHealth today announced that its national testing platform has supported more than 5 million COVID-19 PCR and antibody tests since April 2020.

PWNHealth — a virtual care company focused on diagnostic testing, treatment and guidance — provides its genetic counseling services through phone and video conferencing.

Hundreds of people using the 'Galleri' test from Grail were wrongly told they might have cancer, the company said in a statement Monday.

NEW YORK, Sept. 7, 2018 /PRNewswire-PRWeb/ -- Antidote Technologies, a digital health company with strategic partnerships across the clinical development ecosystem, today announced a collaboration ...

Enabled through a collaboration with PWNHealth and Fulgent Genetics, the testing capabilities expand PRA’ s existing COVID-19 clinical monitoring, ...

Grail said a software glitch related to their telemedicine vendor, PWNHealth, caused them to send letters to about 400 patients saying they might have cancer when they do not.